PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.\', \'Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: ghods.ro@iums.ac.ir.\', \'Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: majdjabari.z@iums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1567-5769(20)32135-410.1016/j.intimp.2020.106942
?:doi
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32896750
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all